Millennium Management
ENZN

Millennium Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Millennium Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-138,932
Closed -$147K – 4158
2015
Q1 		$147K Sell
138,932
-42,426
-23% -$43.9K ﹤0.01% 3357
2014
Q4 		$198K Buy
181,358
+8,538
+5% +$8.96K ﹤0.01% 3638
2014
Q3 		$187K Sell
172,820
-30,979
-15% -$38.2K ﹤0.01% 3454
2014
Q2 		$212K Buy
+203,799
New +$194K ﹤0.01% 3095

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management's ENZN Position: Q2 2015 in Review

Millennium Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2015, closing a stake of 138,932 shares — an estimated $147K sold.

Millennium Management first reported a position in ENZN in Q2 2014 and held it in 4 quarters. The position peaked at $212K in Q2 2014. 58 funds tracked by Wall St. Rank hold ENZN as of Q2 2015.

  • Millennium Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2015 after selling out during the quarter.
  • Millennium Management sold 138,932 ENZON PHARMACEUTICALS INC shares in Q2 2015, an estimated $147K.
  • Millennium Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2014 and held it in 4 quarters.
  • Millennium Management's ENZON PHARMACEUTICALS INC position peaked at $212K in Q2 2014.
  • 58 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.